IFN-γ-producing γδ T cells help control murine West Nile virus infection

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2524-2531

  Wang, Tian ^a   Scully, Eileen ^a,b   Yin, Zhinan ^a   Kim, Jung H ^a   Wang, Sha ^a   Yan, Jun ^a   Mamula, Mark ^a   Anderson, John F ^c   Craft, Joe ^a,b   Fikrig, Erol ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c Connecticut Agric Exp Station ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PERFORIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL TRANSFER; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; INFECTION SENSITIVITY; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD; WEST NILE FLAVIVIRUS;

EID: 0042430331     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2524     Document Type: Article

References (58)

1. Anderson, J. F., T. G. Andreadis, C. R. Vossbrinck, S. Tirrell, E. M. Wakein, R. A. French, A. E. Garmendia, and H. J. Van Kruiningen. 1999. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286:2331.
2. Lanciotti, R. S., J. T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K. E. Volpe, M. B. Crabtree, J. H. Scherret, et al. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333.
3. Roehrig, J. T., M. Layton, P. Smith, G. L. Campbell, R. Nasci, and R. S. Lanciotti. 2002. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr. Top. Microbiol. Immunol. 267: 223.
4. Meek, J. 2002. West Nile virus in the United States. Curr. Opin. Pediatr. 14:72.
5. Campbell, G. L., A. A. Marfin, R. S. Lanciotti, and D. J. Gubler. 2002. West Nile virus. Lancet Infect. Dis. 2:519.
6. Mostashari, F., M. L. Bunning, P. T. Kitsutani, D. A. Singer, D. Nash, M. J. Cooper, N. Katz, K. A. Liljebjelke, B. J. Biggerstaff, A. D. Fine, et al. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358:261.
7. Nash, D., F. Mostashari, A. Fine, J. Miller, D. O'Leary, K. Murray, A. Huang, A. Rosenberg, A. Greenberg, M. Sherman, et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:1807.
8. Xiao, S. Y., H. Guzman, H. Zhang, A. P. Travassos da Rosa, and R. B. Tesh. 2001. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg. Infect. Dis. 7:714.
9. Petersen, L. R., and J. T. Roehrig. 2001. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. 7:611.
10. Petersen, L. R., and A. A. Marfin. 2002. West Nile virus: a primer for the clinician. Ann. Intern. Med. 137:173.
11. Ben-Nathan, D., G. J. Maestroni, S. Lustig, and A. Conti. 1995. Protective effects of melatonin in mice infected with encephalitis viruses. Arch. Virol. 140:223.
12. Wang, T., J. F. Anderson, L. A. Magnarelli, S. J. Wong, R. A. Koski, and E. Fikrig. 2001. Immunization of mice against West Nile virus with recombinant envelope protein. J. Immunol. 167:5273.
13. Campbell, G. L., L. J. Grady, C. Huang, R. Lanciotti, L. Kramer, J. T. Roehrig, and R. E. Shope. 2001. Laboratory testing for West Nile virus: panel discussion. Ann. NY Acad. Sci. 951:179.
14. Lustig, S., H. D. Danenberg, Y. Kafri, D. Kobiler, and D. Ben-Nathan. 1992. Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators. J. Exp. Med. 176:707.
15. Beasley, D. W., L. Li, M. T. Suderman, and A. D. Barrett. 2002. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17.
16. Halevy, M., Y. Akov, D. Ben-Nathan, D. Kobiler, B. Lachmi, and S. Lustig. 1994. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch. Virol. 137:355.
17. Kramer, L. D., and K. A. Bernard. 2001. West Nile virus infection in birds and mammals. Ann. NY Acad. Sci. 951:84.
18. Davis, B. S., G. J. Chang, B. Cropp, J. T. Roehrig, D. A. Martin, C. J., Mitchell, R. Bowen, and M. L. Bunning. 2001. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:4040.
19. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578.
20. Jacoby, R. O., P. N. Bhatt, and A. Schwartz. 1980. Protection of mice from lethal flaviviral encephalitis by adoptive transfer of splenic cells from donors infected with live virus. J. Infect. Dis. 141:617.
21. Shen, J., J. M. Devery, and N. J. King. 1995. Adherence status regulates the primary cellular activation responses to the flavivirus West Nile. Immunology 84:254.
22. Allan, J. E., and P. C. Doherty. 1986. Stimulation of helper/ delayed-type hypersensitivity T cells by flavivirus infection: determination by macrophage procoagulant assay. J. Gen. Virol. 67:39.
23. Kesson, A. M., R. V. Blanden, and A. Mullbacher. 1987. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J. Gen. Virol. 68:2001.
24. Kesson, A. M., R. V. Blanden, and A. Mullbacher. 1988. The secondary in vitro murine cytotoxic T cell response to the flavivirus, West Nile. Immunol. Cell Biol. 66:23.
25. Mashimo, T., M. Lucas, D. Simon-Chazottes, M. P. Frenkiel, X. Montagutelli, P. E. Ceccaldi, V. Deubel, J. L. Guenet, and P. Despres. 2002. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA 99:11311.
26. Sangster, M. Y., D. B. Heliams, J. S. MacKenzie, and G. R. Shellam. 1993. Genetic studies of flavivirus resistance in inbred strains derived from wild mice: evidence for a new resistance allele at the flavivirus resistance locus (Flv). J. Virol. 67:340.
27. Hayday, A. C. 2000. γδ cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18:975.
28. - TCR-γδ-expressing peripheral T cells. J. Immunol. 142:3754.
29. Yin, Z., C. Chen, S. J. Szabo, L. H. Glimche, A. Ray, and J. Craft. 2002. T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-γ by γδ T cells. J. Immunol. 168:1566.
30. Yin, Z., D. H. Zhang, T. Welte, G. Bahtiyar, S. Jung, L. Liu, X. Y. Fu, A. Ray, and J. Craft. 2000. Dominance of IL-12 over IL-4 in γδ T cell differentiation leads to default production of IFN-γ: failure to down-regulate IL-12 receptor β2-chain expression. J. Immunol. 164:3056.
31. Jamieson, A. M., A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, and D. H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17:19.
32. Wang, L., H. Das, Kamath, A. and J. F. Bukowski. 2001. Human Vγ2Vδ2 T cells produce IFN-γ and TNF-α with an on/off/ on cycling pattern in response to live bacterial products. J. Immunol. 167:6195.
33. Cai, J. L., and P. W. Tucker. 2001. γ-5 T cells: immunoregulatory functions and immunoprotection. Chem. Immunol. 79:99.
34. Carding, S. R., and P. J. Egan. 2002. γδ T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2:336.
35. Steele, C. R., D. E. Oppenheim, and A. C. Hayday. 2000. γ(δ) T cells: nonclassical ligands for non-classical cells. Curr. Biol. 10:R282.
36. Kabelitz, D., and D. Wesch. 2001. Role of γδ T-lymphocytes in HIV infection. Eur. J. Med. Res. 6:169.
37. Agrati, C., G. D'Offizi, P. Narciso, C. Selva, L. P. Pucillo, G. Ippolito, and F. Poccia. 2001. γδ T cell activation by chronic HIV infection may contribute to intrahepatic vδ1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 17:1357.
38. Roncella, S., G. Cutrona, M. Truini, I. Airoldi, A. Pezzolo, A. Valetto, D. Di Martino, P. Dadati, A. De Rossi, M. Ulivi, et al. 2000. Late Epstein-Barr virus infection of a hepatosplenic γδ T-cell lymphoma arising in a kidney transplant recipient. Haematologica 85:256.
39. Ohshima, K., S. Haraoka, N. Harada, T. Kamimura, J. Suzumiya, M. Kanda, C. Kawasaki, M. Sugihara, and M. Kikuchi. 2000. Hepatosplenic γδ T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 36:127.
40. Dechanet, J., P. Merville, A. Lim, C. Retiere, V. Pitard, X. Lafarge, S. Michelson, C. Meric, M. M. Hallet, P. Kourilsky, et al. 1999. Implication of γδ T cells in the human immune response to cytomegalovirus. J. Clin. Invest. 103:1437.
41. Rakasz, E., A. Mueller, S. Perlman, and R. G. Lynch. 1999. γδ T cell response induced by vaginal herpes simplex 2 infection. Immunol. Lett. 70:89.
42. Sciammas, R., P. Kodukula, Q. Tang, R. L. Hendricks, and J. A. Bluestone. 1997. T cell receptor-γ/δ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 185:1969.
43. Selin, L. K., P. A. Santolucito, A. K. Pinto, E. Szomolanyi-Tsuda, and R. M. Welsh. 2001. Innate immunity to viruses: control of vaccinia virus infection by γ/δ T cells. J. Immunol. 166:6784.
44. + lymphocytes in the augmented resistance of trehalose 6,6′-dimycolate-treated mice to influenza virus infection. J. Gen. Virol. 78:1597.
45. Benton, K. A., J. A. Misplon, C. Y. Lo, R. R. Brutkiewicz, S. A. Prasad, and S. L. Epstein. 2001. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells. J. Immunol. 166:7437.
46. Lanciotti, R. S., A. J. Kerst, R. S. Nasci, M. S. Godsey, C. J. Mitchell, H. M. Savage, N. Komar, N. A. Panella, B. C. Allen, K. E. Volpe, et al. 2000. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol. 38:4066.
47. + T-cell memory in the respiratory tract. Nat. Med. 8:54.
48. + Th1 cells. J. Virol. 76:10785.
49. + γδ T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-γ. Immunology 99:187.
50. Sciammas, R., and J. A. Bluestone. 1999. TCRγ6 cells and viruses. Microbes Infect. 1:203.
51. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65.
52. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. γ Interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898.
53. Finke, D., U. G. Brinckmann, V. ter Meulen, and U. G. Liebert. 1995. γ Interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469.
54. Leist, T. P., M. Eppler, and R. M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-γ interferon-treated mice. J. Virol. 63:2813.
55. Lane, T. E., A. D. Paoletti, and M. J. Buchmeier. 1997. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine corona-virus. J. Virol. 71:2202.
56. + lymphocytes. J. Virol. 75: 2107.
57. Tseng, C. T., and G. R. Klimpel. 2002. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195:43.
58. Levenbook, I. S., L. J. Pelleu, and B. L. Elisberg. 1987. The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination. J. Biol. Stand. 15:305.